Related Experiment Video
Updated: Aug 27, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
A microencapsulation strategy for intranasal semaglutide delivery
Alberto Baldelli1,2, Hale Oguzlu3, Yilun Weng1
1School of Agriculture and Food Sustainability, The University of Queensland, Brisbane, Australia.
Abstract:
Semaglutide is a widely used treatment for weight loss, conventionally administered by subcutaneous injection. A non-invasive alternative is nasal delivery, which may improve ease of use and patient compliance. This study investigates the spray-drying microencapsulation of semaglutide using water-soluble polymers of varying molecular weights, including polyvinylpyrrolidone (PVP), combined with trehalose as a stabilising sugar. The process achieved over 90% semaglutide retention after three months of storage at 4 °C and encapsulation efficiencies exceeding 95% at a semaglutide concentration of 0.5 mg/mL, using a 1:1 sugar-to-polymer ratio. The resulting formulations fully dissolved in nasal mucus within two hours, with over 30% absorption occurring in the first 20 minutes. Toxicological testing showed no adverse effects on nasal cell lines. Enhanced transport across nasal cells was observed with higher trehalose content, achieving complete transport within two hours.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Intrauterine Drug Delivery Systems
Ophthalmic Drug Delivery Systems

